Skip to main content
. 2017 Oct 24;4(11):811–820. doi: 10.1002/acn3.488

Figure 2.

Figure 2

CART analyses of patients with a SAFE score < 5 at 72 h poststroke. (A) Both TMS and MRI biomarkers available. The analysis selects sensorimotor tract (SMT) lesion load to differentiate between MEP− patients who will have a Limited versus Poor upper limb outcome. (B) TMS but no MRI biomarkers available. The analysis selects NIHSS score to differentiate between MEP− patients who will have a Limited versus Poor upper limb outcome.